Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes.

Camille VatierDina KalbasiMarie-Christine VantyghemOlivier LascolsIsabelle JéruAnne DaguenelJean-François GautierMarion BuyseCorinne Vigouroux

Published in: Orphanet journal of rare diseases (2019)

Metreleptin increases health self-perception and decreases morphotype-associated stigmatization in most patients with lipodystrophic syndromes, but poor comfort of use and local side effects weaken adherence.

Keyphrases

public health
healthcare
mental health
health information
health promotion
skeletal muscle
mesenchymal stem cells